• iCure
• Daewon
• HLB
• phamedaily

Defying the Market Downturn: HLB and Daewon Pharmaceutical Surge on Earnings Growth Expectations ...

• 유진희
• 2026.11.02
• 오전 06:00

CellBion Gains on Renewed Interest in Prostate Cancer Data; Hanmi Pharma Rises 5% on Obesity Drug...

• 손민지
• 2026.10.30
• 오전 07:05

• P&SRobotics
• LivsMed
• MoaLifePlus
• phamedaily

Diverging Market Sentiment: Capital Flows to Proven Performers as Medical Robotics Surge[K-Bio Pu...

• 유진희
• 2026.10.29
• 오전 07:20

• 팜이데일리
• 한미약품
• 올릭스
• 지투지바이오

OliX Slides…What’s Next for OLX301A?[K-Bio Pulse]

• 나은경
• 2026.10.28
• 오전 07:40

• 팜이데일리
• 셀트리온

Celltrion Posts Record Quarterly Revenue, Operating Profit in Third Quarter

• 나은경
• 2026.10.27
• 오전 09:39

• 팜이데일리
• 루닛
• 뷰노
• 의료AI
• 뉴로핏
• 노을

Lunit’s Summit deal lifts Korean medical AI stocks[K-Bio Pulse]

• 나은경
• 2026.10.27
• 오전 07:00

• 팜이데일리
• 셀트리온

Celltrion Adds $70 Million to Share Buybacks as Earnings Rise

• 나은경
• 2026.10.26
• 오후 01:31

• 팜이데일리
• 지투지바이오
• 지구홀딩스
• 퓨쳐켐
• 노을

G2GBIO Surges; Noul, FutureChem Hit Price Limits[K-Bio Pulse]

• 나은경
• 2026.10.26
• 오전 08:00

ECM Treatments Boost Willingness to Donate Human Tissue

• 김진수
• 2026.10.23
• 오후 04:38

• K-bio

Rokit Healthcare Plunges 20% on FDA Warning Letter to U.S. Partner[K-bio Pulse]

• 김승권
• 2026.10.23
• 오전 06:15